NK cells as powerful therapeutic tool in cancer immunotherapy

Mao Huang(Sun Yat-sen University), Wei Xiong(Central South University), Qijia Yan(Central South University), Zhaoyang Zeng(Shenzhen Academy of Robotics), Yongzhen Mo(Central South University), Yong Li(Baylor College of Medicine), Yumin Wang(Central South University), Yixuan Liu(Sun Yat-sen University), Chunmei Fan(Central South University), Peng Miao(Chinese Academy of Sciences), Fuyan Wang(Central South University), Junshang Ge(Central South University)
Cellular Oncology
January 3, 2024
10.1007/s13402-023-00909-3
Cited by 12

Related Papers

Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619